Log In
Print
BCIQ
Print
Print this Print this
 

FGFR inhibitor (JNJ42756493)

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionFibroblast growth factor receptor (FGFR) kinase inhibitor
Molecular Target Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Johnson & Johnson


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today